EU Drug Policy Campaign 2025: A Call to Invest in a European Health-Based Drug Policy
In 2025, the European Union will adopt a new EU Drug Strategy that will define priorities for 2026–2030. As this critical moment approaches, we call for a shift towards a balanced, health-focused, and human rights-based approach to drug policy.
To support this effort, we are supporting the EU Drug Policy Campaign 2025, coordinated by C-EHRN in collaboration with the Eurasian Harm Reduction Association (EHRA), International Drug Policy Consortium (IDPC), and Helsinki Foundation for Human Rights (HFHR). The campaign is accompanied by the publication of a new policy paper, a communication and advocacy toolkit, and an upcoming webinar on June 26, 2025, organised on the Support Don’t Punish Global Day of Action.
Policy Paper: Harm Reduction Works!
The new policy paper outlines urgent recommendations for the EU and Member States, including:
- Making drug use an EU health priority
- Ensuring a balanced EU Drug Strategy 2026–2030
- Establishing dedicated EU-level funding for harm reduction
- Prioritising decriminalisation and responsible regulation
Communication Package & Advocacy Toolkit
This toolkit supports civil society and national stakeholders to engage with policymakers at both the EU and national levels. It includes:
- A Canva template for translating the policy paper
- Ready-to-use social media content and visuals
- Customisable email templates for outreach
- Advocacy tips and ideas for national action
Join The Webinar
The webinar will be held on: June 26, 2025 | 12:00–13:00 CEST, coinciding with the Support Don’t Punish Global Day of Action. You can register here.
There, presenters will speak about the campaign’s goals and share ways civil society organisations and allies can get involved.
New Policy Brief Out: Where There Is Fruit, There Is Seed: Scaling Up Community Involvement for Integrated, Responsive, and Sustainable Harm Reduction
This policy brief underscores the transformative potential of community-led responses in driving sustainable harm reduction strategies. It highlights the indispensable role of c
New policy brief calls for a decriminalisation model whereby all drugs are decriminalised
The criminalisation of use, possession for personal use, and other related behaviours may have negative impact on people who use drugs, local communities, and the whole society,
No Health Without Rights: New Policy Brief Urges Universal Health Coverage for People Who Use Drugs in Europe
In 2025, the European Union will adopt a new EU Drug Strategy that will define priorities for 2026–2030. As this critical moment approaches, we call for a shift towards a
EU Drug Policy Campaign 2025: A Call to Invest in a European Health-Based Drug Policy
In 2025, the European Union will adopt a new EU Drug Strategy that will define priorities for 2026–2030. As this critical moment approaches, we call for a shift towards a
BOOST at the 68th CND: Amplifying Advocacy for Health and Rights
From 10–14 March 2025, BOOST partners took part in the 68th session of the Commission on Narcotic Drugs (CND) in Vienna, using this global platform to advance strategic ad
Final Digital Expert Meeting: Defining Quality Standards for Digital Harm Reduction
On February 17-18, the final Digital Expert Meeting took place at the ISGlobal offices in Barcelona, bringing together experts in harm reduction and digital health to complete t
Shape the Future of Digital Harm Reduction – Join the 2nd Round of the Delphi Study
The BOOST project is working to establish quality standards for digital harm reduction services, supporting community-based and community-led organisations in providing eff
Call for applications for consultant to map availability, accessibility, and needs for Harm Reduction Services
Consultant to map availability, accessibility and needs for HarmReduction Services in Southeastern Europe Consultant to map availability, accessibility and needs for HarmReducti
Bring Your Expertise to Shape Digital Harm Reduction Quality Standards – Join the Delphi Study Call
Bring Your Expertise to Shape Digital Harm Reduction Quality Standards – Join the Delphi Study Digital harm reduction services are rapidly evolving, with a growing diversi
